
Portal Biotech
Bench-top nanopore solutions for single-molecule protein characterisation.
Date | Investors | Amount | Round |
---|---|---|---|
* | $35.0m | Series A | |
Total Funding | 000k |
Related Content
Portal Biotech Limited specializes in advanced proteomic and metabolomic analysis, offering real-time data solutions that provide fast and comprehensive answers to biological questions. The company's technology allows for complete coverage of proteins at the single molecule level, ensuring no loss of information during analysis. Portal Biotech serves both small and high-volume laboratories with accessible and affordable instruments and cartridges, integrating seamlessly into existing workflows. The business operates in the life sciences market, focusing on proteoform quantitation and profiling, which is crucial for developing better diagnostics and drug designs. Revenue is generated through the sale of instruments and consumables, catering to the needs of research institutions and biotech companies.
Keywords: proteomics, metabolomics, real-time data, protein analysis, single molecule, laboratory instruments, diagnostics, drug design, proteoform, biological research.